The VITROS 5600 is an integrated system that brings together 5 proven technologies designed to remove the obstacles to reducing turnaround time; this family of products will be showcased at the AACC.
Ortho Clinical Diagnostics announced it will present seven scientific posters on its assays and display six products at its booth at the 2016 American Association for Clinical Chemistry (AACC) annual meeting.
The conference will be held from July 31 to August 4, 2016 in Philadelphia’s Pennsylvania Convention Center. Ortho’s posters will address a range of important tests, both marketed and in-development for clinical labs, including HIV, Chagas disease and thyroid function.
The posters Ortho will display at the conference are:
- Evaluation of the Performance of the VITROS Immunodiagnostic Products HIV Combo Assay* at Two European Trial Sites
- Poster Session: August 3 from 9:30 a.m. to 5 p.m.; Infectious Disease (13)
- Author Presentation: 12:30 – 1:30 p.m.
- Presenter: Paul Contestable, principal scientist, Ortho Clinical Diagnostics
- Development of a High Sensitivity Prototype Assay* for Thyroid Stimulating Hormone
- Poster Session: August 2 from 9:30 a.m. to 5 p.m.; Endocrinology/Hormones (04)
- Author Presentation: 12:30 – 1:30 p.m.
- Presenter: Phil Hosimer, senior principal scientist, Ortho Clinical Diagnostics
- Development of an Enhanced Chemiluminescent C-peptide Assay*
- Poster Session: August 2 from 9:30 a.m. to 5 p.m.; Endocrinology/Hormones (04)
- Author Presentation: 12:30 – 1:30 p.m.
- Presenter: Holly Groth, staff scientist, Ortho Clinical Diagnostics
- Standardization and Harmonization of Ortho Clinical Diagnostics Thyroid Function Tests
- Poster Session: August 2 from 9:30 a.m. to 5 p.m.; Endocrinology/Hormones (04)
- Author Presentation: 12:30 – 1:30 p.m.
- Presenter: Chris Thomas, principal scientist, Ortho Clinical Diagnostics
- Evaluation of the Performance of the New VITROS LDHI Assay Slide
- Poster Session: August 3 from 9:30 a.m. to 5 p.m.; Proteins/Enzymes (19)
- Author Presentation: 12:30 – 1:30 p.m.
- Presenter: Scott Hewitson, senior scientist, Ortho Clinical Diagnostics
- Performance of a Prototype T. cruzi Assay* for the Detection of Chagas Disease
- Poster Session: August 3 from 9:30 a.m. to 5 p.m.; Infectious Disease (13)
- Author Presentation: 12:30 – 1:30 p.m.
- Presenter: Sue Danielson, research fellow, Ortho Clinical Diagnostics
- Comparative Study of Six Sigma Assay Performance on VITROS Systems
- Poster Session: August 3 from 9:30 a.m. to 5 p.m.; Management (15)
- Author Presentation 12:30 – 1:30 p.m.
- Presenter: Andy Kirsch, manager, systems support and field triage, Ortho Clinical Diagnostics
Products on display in Ortho’s booth (No. 1100) at AACC will include Ortho’s flagship Integrated Clinical Chemistry and Immunodiagnostic Systems and the Nephrocheck Test. Ortho will also highlight the company’s transfusion medicine instrument, The ORTHO VISION MAX.**
Visitors to the booth will also be able to witness how the enGen Laboratory Automation system, used in combination with the VITROS Systems and informatics solutions, helps clinical labs automate, streamline and standardize workflow. Auto-verification improves security, increases walk-away time and diminishes costs, allowing lab professionals to more efficiently manage testing.
The company will also host an invitation-only customer event at the Franklin Institute on Tuesday, August 2, from 5 p.m. to 9:30 p.m., featuring a session on empowering lab directors to work effectively with C-level hospital executives, as well as a lecture on the changing landscape of heart failure biomarkers.
Another highlight of Ortho’s presence at the meeting will be an in-booth virtual reality lab visualization station. Using the latest 3D technology, visitors will work with our design team to custom build their own dream laboratories.
They’ll then tour the creations through virtual reality, learning how proprietary Ortho technology allows labs to grow and change as their needs do. The booth will also feature a theatre with a rotating roster of key opinion leader presentations and a lab informatics station.
*In development: Not approved or cleared in the U.S.
**Pending 510(k) clearance
Ortho Clinical Diagnostics
orthoclinical.com
